We are a public-private collaboration between 17 U.K. universities and over 50 industrial and supporting partners, ranging from start-ups to large multinationals, such as GSK, Shell and Microsoft. Our supporting partners are equally varied including regional and local government.

Our goal is to facilitate the translation of research outputs from synthetic biology into commercial products and services by acting as a bridge between university and industry. We encourage early engagement and communication between our academic and industrial partners to ensure that the research outputs are able to scale and have impact.